Results 81 to 90 of about 81,928 (305)

The Basophil Activation Test Is Not a Useful Screening Tool for Hymenoptera Venom-Related Anaphylaxis in Patients with Systemic Mastocytosis [PDF]

, 2016
Background: Systemic mastocytosis (SM) patients are at a high risk for anaphylaxis, with Hymenoptera as the main culprit. A screening instrument to identify which patients are sensitized to Hymenoptera before they experience anaphylaxis would therefore ...
Daele, P.L.A. (Paul) van, Gerth van Wijk, R. (Roy), Hermans, M.A.W. (Maud A.W.), Rietveld, M.J.A. (Mark J.A.), Schreurs, M.W.J. (Marco)   +4 more
core   +1 more source

NCCN Guidelines® Insights: Systemic Mastocytosis, Version 3.2024.

The Journal of the National Comprehensive Cancer Network
Mastocytosis is a heterogeneous group of disorders comprising cutaneous mastocytosis, systemic mastocytosis, and mast cell sarcoma. It is associated with a variety of symptoms related to the release of mast cell mediators and mast cell tissue ...
J. Gotlib, A. Gerds, Peter Abdelmessieh, H. Ali, M. Castells, Andrew Dunbar, Ruth Fein Revell, Tracy I. George, Steven Green, Krishna Gundabolu, Elizabeth O. Hexner, Tania Jain, C. Jamieson, P. Kaesberg, Andrew T Kuykendall, Y. Madanat, Naveen Manchanda, L. Masarova, Jori May, Brandon McMahon, Sanjay R Mohan, Kalyan V Nadiminti, Stephen Oh, Jeanne Palmer, Ami Patel, Anand A Patel, Nikolai Podoltsev, Lindsay Rein, R. Salit, Moshe Talpaz, M. Wadleigh, Sarah A Wall, Mary Anne Bergman, Cindy Hochstetler   +33 more
semanticscholar   +1 more source

CD30 as a Target Molecule in the Diagnosis and Therapy of Lymphomas

American Journal of Hematology, EarlyView.
ABSTRACT The tumor necrosis factor (TNF)‐receptor superfamily 8 receptor CD30 molecule is expressed in all tumor cells of Hodgkin lymphoma and anaplastic large cell lymphoma but is only weakly expressed in a small subset of large lymphoid cells in normal peripheral lymphoid tissues.
Harald Stein, Brunangelo Falini
wiley   +1 more source

Drug hypersensitivity reactions and allergy in patients with mastocytosis

Przegląd Dermatologiczny, 2017
Mastocytosis is a rare myeloproliferative disease caused by excessive proliferation and accumulation of mast cells in the skin and internal organs. The most common variant of mastocytosis in children is cutaneous mastocytosis.
Justyna H. Czarny, Magdalena Lange, Marek B. Niedoszytko, Barbara Kwiecińska, Aleksandra Górska, Hanna Ługowska-Umer, Monika Sikorska, Roman Nowicki   +7 more
doaj   +1 more source

Comprehensive mastocytosis data analysis from a single center

BMC Cancer, 2023
Mastocytosis is a very rare disorder and is divided into three prognostically distinct variants by World Health Organization: Cutaneous mastocytosis (CM), systemic mastocytosis (SM), and mast cell sarcoma or localized mast cell (MC) tumors.
Tarık Onur Tiryaki, Sıdıka Gülkan Özkan, Simge Erdem, Aynur Dağlar Aday, İpek Yönal Hindilerden, Aslı Gelincik, Can Baykal, Gülçin Yegen, İbrahim Öner Doğan, Nesimi Büyükbabani, Meliha Nalçacı, Akif Selim Yavuz   +11 more
doaj   +1 more source

Bone Marrow Mastocytosis: A Diagnostic Challenge

Journal of Clinical Medicine, 2021
Bone marrow mastocytosis (BMM) represents a provisional, indolent subvariant of systemic mastocytosis (SM). Utilizing WHO criteria, BMM requires bone marrow (BM) involvement and the absence of mastocytosis skin lesions.
R. Zanotti, I. Tanasi, Andrea Bernardelli, G. Orsolini, P. Bonadonna   +4 more
semanticscholar   +1 more source

Genomics and Histopathology in Interstitial Cystitis/Bladder Pain Syndrome

Neurourology and Urodynamics, EarlyView.
ABSTRACT Aims In April of 2025, a Global Consensus meeting on IC/BPS was held in Winston‐Salem, NC. The goal of this meeting was to establish global consensus in diagnostic criteria, phenotyping, treatment outcome assessment, and possible etiopathology in interstitial cystitis/bladder pain syndrome (IC/BPS).
Hannah Ruetten, LaTasha K. Crawford, Elise J. B. De, Wencheng Li, Yoshiyuki Akiyama   +4 more
wiley   +1 more source

Difficulties in diagnosis and management of mastocytosis in clinical practice and role of patients' associations [PDF]

Romanian Journal of Medical Practice, 2017
Mastocytosis is a heterogeneous group of disorders characterized by abnormal expansion and accumulation of mast cells in one or more organs. It is a rare disease, with uncertain prevalence in many countries. The diagnosis and management of rare diseases,
Polliana Mihaela LERU, Dumitru MATEI
doaj   +1 more source

An adolescent girl with signs and symptoms of anaphylaxis and negative immunologic workup: a case report. [PDF]

, 2020
BackgroundThe increasing incidence of allergies and allergic reactions among children and adults has become a major public health concern. The etiology of allergic reactions can often be confirmed based on a detailed history and supportive testing ...
Bauer, Maureen, Frank, Guido KW, Green, Sarah, Hicks, Allison, Hilsendager, Chelsea   +4 more
core  

Vascular endothelial growth factors and angiopoietins as new players in mastocytosis

Clinical and Experimental Medicine (Testo stampato), 2021
Mastocytosis is a disorder characterized by the abnormal proliferation and/or accumulation of mast cells in different organs. More than 90% of patients with systemic mastocytosis have a gain-of-function mutation in codon 816 of the KIT receptor on mast ...
Simone Marcella, A. Petraroli, Mariantonia Braile, R. Parente, A. L. Ferrara, M. Galdiero, Luca Modestino, Leonardo Cristinziano, F. Rossi, G. Varricchi, M. Triggiani, A. de Paulis, G. Spadaro, S. Loffredo   +13 more
semanticscholar   +1 more source